DLX-2270
DLX-2270 is an experimental serotonin receptor modulator which is under investigation for the potential treatment of schizophrenia. It acts as a serotonin 5-HT2A receptor antagonist and serotonin 5-HT2C receptor agonist.
DLX-2270 is an experimental serotonin receptor modulator which is under investigation for the potential treatment of schizophrenia. It acts as a serotonin 5-HT2A receptor antagonist and serotonin 5-HT2C receptor agonist.
DLX-2270 is an experimental serotonin receptor modulator which is under investigation for the potential treatment of schizophrenia. It acts as a serotonin 5-HT2A receptor antagonist and serotonin 5-HT2C receptor agonist.
Source: Wikipedia "DLX-2270" · CC BY-SA 4.0
Share this article: X · Bluesky